Showing results (51-60 of 210) with videos related to

Sort By:
Pageof 21
Annals of Neurology|January 27, 2006
Association of the PTPN22*R620W polymorphism with autoimmune myasthenia gravisClaire Vandiedonck, Claire Capdevielle, Matthieu Giraud, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2004
Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasiaClaire Vandiedonck, Geneviève Beaurain, Matthieu Giraud, et al.
Neuromuscular Disorders : NMD|June 2, 2009
Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: a case control studyKarim Wahbi, Christophe Meune, Henri Marc Bécane, et al.
Clinical Therapeutics|October 8, 2009
Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trialDavid Orlikowski, Sylvie Chevret, Maria Antonia Quera-Salva, et al.
The Journal of Pathology|September 24, 2005
The origin of tubular aggregates in human myopathiesFrédéric Chevessier, Stéphanie Bauché-Godard, Jean-Paul Leroy, et al.
Neuromuscular Disorders : NMD|February 6, 2018
Genotype and other determinants of respiratory function in myotonic dystrophy type 1Ghilas Boussaïd, Karim Wahbi, Pascal Laforet, et al.
Journal of Neurology|February 1, 2011
A novel MYH7 mutation occurring independently in French and Norwegian Laing distal myopathy families and de novo in one Finnish patientOdile Dubourg, Thierry Maisonobe, Anthony Behin, et al.
Neuromuscular Disorders : NMD|March 17, 2007
A synonymous CHRNE mutation responsible for an aberrant splicing leading to congenital myasthenic syndromePascale Richard, Karen Gaudon, Emmanuel Fournier, et al.
Neuromuscular Disorders : NMD|April 25, 2008
Severe neonatal myasthenia due to maternal anti-MuSK antibodiesAnthony Béhin, Michèle Mayer, Bouchera Kassis-Makhoul, et al.
American Heart Journal|August 28, 2007
Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-upDenis Duboc, Christophe Meune, Bertrand Pierre, et al.
Pageof 21